title: [Müllerian mixed tumors. Experience of the Rennes Regional University Hospital].
abstract: Seventeen cases of mixed Muller tumours (tumours of the uterus with malignant epithelial and mesenchymal components) are presented. These recently described tumours are rare and occur in menopaused women. Bloody discharge is the usual clinical manifestation, together with an increase of the volume of the uterus. Pathology examination of the surgical specimen is required for diagnosis using immunolabeling to distinguish between homologous tumours (the sarcomatous component occurs in the primary mesenchyma) and heterologous tumours (the mesenchymatous component results from a metastasis). Prognosis, usually poor, depends on the stage of the tumour. Overall survival at 5 years is about 30%. Survival in early stage I and state II tumours is no greater than 50% at 5 years. Treatment is based on radiosurgical techniques in less advanced tumours and requires radiochemotherapy in more advanced stage tumours. Recurrence is usually seen within 2 years, involving the pelvis alone in 10% of the cases and metastasis in most of the others. Because of their rapid development and poor prognosis, these tumours should be identified separately as a separate entity within a larger group of mixed mesodermic tumours.
authors.affiliation: C.H.R.U. de Rennes.
authors.forename: J
authors.initials: J
authors.lastname: Leveque
authors.forename: V
authors.initials: V
authors.lastname: Paumier
authors.forename: P
authors.initials: P
authors.lastname: Poulain
authors.forename: P Y
authors.initials: PY
authors.lastname: Moquet
authors.forename: J
authors.initials: J
authors.lastname: Kerisit
authors.forename: J R
authors.initials: JR
authors.lastname: Giraud
authors.forename: J Y
authors.initials: JY
authors.lastname: Grall
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D005260:Female; D005602:France; D006764:Hospitals, Community; D006801:Humans; D008875:Middle Aged; D018200:Mixed Tumor, Mullerian / Q000196:embryology / Q000473:pathology / Q000628:therapy; D011379:Prognosis; D013997:Time Factors; D014594:Uterine Neoplasms / Q000196:embryology / Q000473:pathology / Q000628:therapy